Order Article Reprints

Dubois C, Daumar P, Aubel C, Gauthier J, Vidalinc B, Mounetou E, Penault-Llorca F, Bamdad M. The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines. Journal of Clinical Medicine. 2019; 8(3):397. https://doi.org/10.3390/jcm8030397

Dubois, Clémence, Pierre Daumar, Corinne Aubel, Jean Gauthier, Bernard Vidalinc, Emmanuelle Mounetou, Frédérique Penault-Llorca, and Mahchid Bamdad. 2019. "The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines" Journal of Clinical Medicine 8, no. 3: 397. https://doi.org/10.3390/jcm8030397

Dubois, C., Daumar, P., Aubel, C., Gauthier, J., Vidalinc, B., Mounetou, E., Penault-Llorca, F., & Bamdad, M. (2019). The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines. Journal of Clinical Medicine, 8(3), 397. https://doi.org/10.3390/jcm8030397